The rationale for drug combinations in age-related macular degeneration.
Retina
; 29(6 Suppl): S42-4, 2009 Jun.
Article
em En
| MEDLINE
| ID: mdl-19553800
ABSTRACT
The strategies for improving control of age-related macular degeneration with combination therapies are evolving. The focus on more effective blockade of choroidal neovascularization has shifted to include control of additional processes implicated in disease progression, such as neural death, inflammation, or fibrosis. Although there is likely to be a strong interrelationship between choroidal neovascularization and inflammation that contributes to advanced stages of disease progression, including fibrosis, combining treatment strategies may enlarge the opportunity to prevent both early and late vision loss.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neovascularização de Coroide
/
Quimioterapia Combinada
/
Degeneração Macular
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Retina
Ano de publicação:
2009
Tipo de documento:
Article
País de afiliação:
Estados Unidos